About This Research Desk

What Chai Peptide is

Chai Peptide is a plain-language reader for two peptides studied around calm, focus, and sleep: DSIP and Semax, with Semax in the lead. Its job is to take a scattered, frequently overstated body of research and say plainly — honestly, and with citations — what each compound was actually studied for, in which species, and how far that evidence really goes.

The organizing idea is a daily rhythm: DSIP anchors the sleep end, Semax anchors the focus end. Reading them together gives a clearer picture of the range of evidence quality in this space than either alone — DSIP's mechanism remains, by researchers' own description, an unresolved riddle, while Semax has a far more specific and measurable mechanism but a much narrower geographic base of human use. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every source used across both.

How it is compiled

Three habits shape what lands on these pages.

One, every research claim is pinned to a numbered citation. Each factual line traces back to a source on the references page — peer-reviewed journal articles, PubMed-indexed studies, and reviews, with DOIs and PubMed links where they exist.

Two, evidence is described at its real strength, not its marketed one. A rodent result is called a rodent result. A 1980s human pilot study is called exactly that — small, old, and never repeated at scale. Where the literature flatly contradicts a popular claim, as it does with DSIP and sleep, the contradiction is stated outright instead of being smoothed over.

Three, anecdote is fenced off from clinical evidence. Wherever these pages relay what people say about DSIP or Semax in forums and writeups, the material is labeled anecdotal, not clinical evidence, and a community report is never turned into a dosing suggestion.

What it is not

None of this is a pharmacy, a clinic, a telehealth platform, or a storefront. Chai Peptide sells nothing, supplies nothing, sources nothing, and brokers nothing — not DSIP, not Semax, not any other compound — and it keeps no affiliate or referral tie to any research-chemical vendor. It has no clinicians on staff; it diagnoses nobody and names no dose, schedule, or route for anyone.

Semax is a registered prescription medicine only in Russia and Ukraine; DSIP is approved as a medicine nowhere. For clinical guidance, see a licensed provider where you live. Notes about citation fixes or newly published research are welcome through the contact page, though nothing here answers requests for medical advice.